A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion

NCT01308541 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Monitored Anesthesia Care

Interventions

DRUG: arm 1
DRUG: LUSEDRA
DRUG: Propofol (arm 3)

Sponsor

Eisai Inc.